Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) FCF Margin (2020 - 2022)

Historic FCF Margin for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to 1778.89%.

  • Therapeutics' FCF Margin fell 1701500.0% to 1778.89% in Q2 2022 from the same period last year, while for Mar 2023 it was 8493.23%, marking a year-over-year decrease of 65324900.0%. This contributed to the annual value of 4689.98% for FY2022, which is 30697100.0% down from last year.
  • Latest data reveals that Therapeutics reported FCF Margin of 1778.89% as of Q2 2022, which was down 1701500.0% from 2453.51% recorded in Q1 2022.
  • Therapeutics' 5-year FCF Margin high stood at 503.29% for Q2 2020, and its period low was 2787.7% during Q4 2021.
  • Over the past 3 years, Therapeutics' median FCF Margin value was 1248.38% (recorded in 2020), while the average stood at 1439.12%.
  • Per our database at Business Quant, Therapeutics' FCF Margin tumbled by -15941500bps in 2021 and then tumbled by -1701500bps in 2022.
  • Over the past 3 years, Therapeutics' FCF Margin (Quarter) stood at 1193.55% in 2020, then plummeted by -134bps to 2787.7% in 2021, then surged by 36bps to 1778.89% in 2022.
  • Its FCF Margin stands at 1778.89% for Q2 2022, versus 2453.51% for Q1 2022 and 2787.7% for Q4 2021.